These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29051265)

  • 1. Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT.
    Court H; Ahearn IM; Amoyel M; Bach EA; Philips MR
    J Cell Biol; 2017 Dec; 216(12):4165-4182. PubMed ID: 29051265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.
    Court H; Amoyel M; Hackman M; Lee KE; Xu R; Miller G; Bar-Sagi D; Bach EA; Bergö MO; Philips MR
    J Clin Invest; 2013 Nov; 123(11):4681-94. PubMed ID: 24216479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab GTPases containing a CAAX motif are processed post-geranylgeranylation by proteolysis and methylation.
    Leung KF; Baron R; Ali BR; Magee AI; Seabra MC
    J Biol Chem; 2007 Jan; 282(2):1487-97. PubMed ID: 17114793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells.
    Bergo MO; Leung GK; Ambroziak P; Otto JC; Casey PJ; Young SG
    J Biol Chem; 2000 Jun; 275(23):17605-10. PubMed ID: 10747846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenylcysteine carboxyl methyltransferase deficiency in mice.
    Bergo MO; Leung GK; Ambroziak P; Otto JC; Casey PJ; Gomes AQ; Seabra MC; Young SG
    J Biol Chem; 2001 Feb; 276(8):5841-5. PubMed ID: 11121396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Chai TF; Manu KA; Casey PJ; Wang M
    Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Isoprenylcysteine Carboxyl Methyltransferase (ICMT) Leads to Progressive Loss of Photoreceptor Function.
    Christiansen JR; Pendse ND; Kolandaivelu S; Bergo MO; Young SG; Ramamurthy V
    J Neurosci; 2016 May; 36(18):5107-14. PubMed ID: 27147662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
    Cushman I; Casey PJ
    J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratum recruits Rab8 at Golgi exit sites to regulate the basolateral sorting of Notch and Sanpodo.
    Bellec K; Gicquel I; Le Borgne R
    Development; 2018 Jul; 145(13):. PubMed ID: 29967125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenylation of Rab8 GTPase by type I and type II geranylgeranyl transferases.
    Wilson AL; Erdman RA; Castellano F; Maltese WA
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):497-504. PubMed ID: 9677305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.
    Bergo MO; Gavino BJ; Hong C; Beigneux AP; McMahon M; Casey PJ; Young SG
    J Clin Invest; 2004 Feb; 113(4):539-50. PubMed ID: 14966563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane.
    Ahearn IM; Court HR; Siddiqui F; Abankwa D; Philips MR
    Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33579760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
    Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
    Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation.
    Lu Q; Harrington EO; Hai CM; Newton J; Garber M; Hirase T; Rounds S
    Circ Res; 2004 Feb; 94(3):306-15. PubMed ID: 14699010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RHO methylation matters: a role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion.
    Cushman I; Casey PJ
    Cell Adh Migr; 2011; 5(1):11-5. PubMed ID: 20798596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the ternary complex between Rab7, REP-1 and Rab geranylgeranyl transferase.
    Alexandrov K; Simon I; Yurchenko V; Iakovenko A; Rostkova E; Scheidig AJ; Goody RS
    Eur J Biochem; 1999 Oct; 265(1):160-70. PubMed ID: 10491170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the integral membrane methyltransferase isoprenylcysteine carboxyl methyltransferase (ICMT) reveals potential substrate binding sites.
    Diver MM; Long SB
    J Biol Chem; 2014 Sep; 289(38):26007-26020. PubMed ID: 25059662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease.
    Wahlstrom AM; Cutts BA; Liu M; Lindskog A; Karlsson C; Sjogren AK; Andersson KM; Young SG; Bergo MO
    Blood; 2008 Aug; 112(4):1357-65. PubMed ID: 18502828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.